The Power of Precision Medicine is Exemplified by Tempus
For some patients, a key step to finding their best treatment may be molecular testing of their tumor tissue. This type of test could reveal distinct features, such as genetic […]
Entries by melindaroberts
Helping Cancer Patients Access their Own Health Data
For many cancer patients, the ability to access one’s own medical records can aid their treatment decisions, or allow them to donate their personal data for research that could help […]
10th Annual Lundberg Institute Lecture: American Healthcare: What’s Left After COVID-19
Virtual Lecture: Further Details TBD Moderator George D Lundberg MS, MD, ScD (hon) President and Chair of the Board of Directors, The Lundberg Institute; Editor in Chief, Cancer Commons; Editor […]
How I Cope with the Tsunami of Cancer and COVID-19 Info
Oncologists worldwide face the challenge of staying on top of the latest treatments, research findings, and other information that could help them treat their patients more effectively. Now, they must […]
How the Coronavirus Pandemic Impacts Cancer Care: Our Survey Results
The ongoing COVID-19 pandemic presents unprecedented challenges to cancer patients. Many have experienced changes to their care, and some face increased risk of infection or worse prognosis if they are […]
The Challenges of Using Artificial Intelligence to Improve Cancer Treatment
In a previous post, CureMatch co-founder Razelle Kurzrock, MD, told us all about her company’s artificial intelligence (AI) platform that matches patients with treatments based on their cancer’s molecular profile. […]
How to Beat COVID-19 with Real-Time, Real-World Data
As the COVID-19 pandemic continues, researchers around the world are working quickly to develop strategies to treat and prevent this disease. In partnership with the company xCures, Cancer Commons is […]
What Sets Cancer Commons Apart?
Cancer Commons is a patient-centric, nonprofit network of patients, physicians, and scientists that helps identify the best options for treating an individual’s cancer. Here, our Curious Dr. George asks executive […]
Facilitating Access to Treatment for Children with Brain Cancer
A Q&A with Leslie Jared, RN, MSN, Nurse Navigator at Cancer Commons. Email: leslie.jared@cancercommons.org Q: A midline glioma is a type of brain tumor that is particularly dangerous because of its […]
Using Artificial Intelligence to Match Combination Targeted Therapies in Oncology
A Q&A with Razelle Kurzrock, MD, Director of the Center for Personalized Cancer Therapy and the Rare Tumor Clinic at U.C. San Diego, and Co-Founder and Board Member of CureMatch, […]